CCTG Committee on Economic Analysis Co-Chair Dr. Nicole Mittmann is the Canadian Agency for Drugs and Technologies in Health (CADTH) Chief Scientist and Vice-President of Evidence Standards. Dr. Mittmann leads CADTH’s shared science groups, including the Health Economics, Research Information Services, and Scientific Affairs teams. In her academic capacity, Dr. Mittmann holds a faculty position at the University of Toronto in both the Department of Pharmacology and Toxicology and the Institute for Health, Policy, Management and Evaluation. As an Associate Scientist at Sunnybrook Health Sciences Centre in Toronto she conducted and collaborated on notable research in the areas of economic evaluations, observational outcomes research and drug/patient safety. Dr. Mittmann has conducted and collaborated on notable research in the areas of economic evaluations, outcomes research, and drug/patient safety. Research methodologies include the examination of large databases, economic methodologies, and decision analysis. Most significant work includes leading the construction of economic guidelines for oncology products and constructing costing algorithms for Ontario administrative databases to enable disaggregated costing, comparative analyses for models of care and real world cost-effectiveness analyses. "The work that the Committee on Economic Analysis undertakes is important to ensure that economic variables are embedded into the clinical trial design from the start and therefore ensure that decision makers have the data to make informed decision on new technologies." Research interests Health economic and outcomes research Construction of economic guidelines for oncology products Comparative analyses for models of care and real world cost-effectiveness analyses
